Evolutionary Genomics, Inc.

FNAM · OTC
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Activities
Net Income-$1,935-$2,794-$1,712-$793
Dep. & Amort.$1,021$1,039$409$41
Deferred Tax$0$0-$987$32
Stock-Based Comp.$193$220$220$56
Change in WC$79$36-$47$52
Other Non-Cash$0-$83-$180-$13
Operating Cash Flow-$641-$1,583-$2,297-$626
Investing Activities
PP&E Inv.-$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$148$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$148$0
Financing Activities
Debt Repay.$0$1,581$2,320$0
Stock Issued$550$0$0$540
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$454$0$0$540
Financing Cash Flow$1,004$1,581$2,320$540
Forex Effect$0$0$0$0
Net Chg. in Cash$363-$2$170-$86
Supplemental Information
Beg. Cash$214$216$45$131
End Cash$577$214$216$45
Free Cash Flow-$641-$1,583-$2,297-$626